0001069530-22-000039.txt : 20220824
0001069530-22-000039.hdr.sgml : 20220824
20220824160205
ACCESSION NUMBER: 0001069530-22-000039
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220823
FILED AS OF DATE: 20220824
DATE AS OF CHANGE: 20220824
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kupiec James William
CENTRAL INDEX KEY: 0001839551
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-29959
FILM NUMBER: 221191533
MAIL ADDRESS:
STREET 1: 7801 N CAPITAL OF TEXAS HIGHWAY
STREET 2: SUITE 260
CITY: AUSTIN
STATE: TX
ZIP: 78731
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CASSAVA SCIENCES INC
CENTRAL INDEX KEY: 0001069530
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 911911336
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 7801 N CAPITAL OF TEXAS HIGHWAY
STREET 2: SUITE 260
CITY: AUSTIN
STATE: TX
ZIP: 78731
BUSINESS PHONE: 512-501-2444
MAIL ADDRESS:
STREET 1: 7801 N CAPITAL OF TEXAS HIGHWAY
STREET 2: SUITE 260
CITY: AUSTIN
STATE: TX
ZIP: 78731
FORMER COMPANY:
FORMER CONFORMED NAME: PAIN THERAPEUTICS INC
DATE OF NAME CHANGE: 20000309
4
1
certent-form4.xml
PRIMARY DOCUMENT
X0306
4
2022-08-23
0001069530
CASSAVA SCIENCES INC
SAVA
0001839551
Kupiec James William
C/O CASSAVA SCIENCES, INC.
7801 N CAPITAL OF TEXAS HWY, SUITE 260
AUSTIN
TX
78731
0
1
0
0
Chief Clinical Dev. Officer
Common Stock
2022-08-23
4
P
0
2500
24.44
A
2500
D
The purchase reported in column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $24.41 to $24.44 per share. The reporting person undertakes to provide to Cassava, any security holder of Cassava or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each price within the range set forth in this footnote.
/s/JAMES KUPIEC
2022-08-24